TY - JOUR AU - Hager, K. AU - Baseman, A. S. AU - Nye, J. S. AU - Brashear, H. R. AU - Han, J. AU - Sano, M. PY - 2014 DA - 2014// TI - Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer’s disease JO - Neuropsychiatr Dis Trea VL - 10 ID - Hager2014 ER - TY - JOUR AU - Nagino, K. AU - Shikinami, K. AU - Saito, T. AU - Harada, Y. PY - 2001 DA - 2001// TI - Pharmacological and clinical profiles of galantamine JO - Nihon Yakurigaku Zasshi VL - 138 UR - https://doi.org/10.1254/fpj.138.122 DO - 10.1254/fpj.138.122 ID - Nagino2001 ER - TY - JOUR AU - Raskind, M. A. AU - Peskind, E. R. AU - Wessel, T. AU - Yuan, W. PY - 2000 DA - 2000// TI - Galantamine in AD: a 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group JO - Neurology VL - 54 UR - https://doi.org/10.1212/WNL.54.12.2261 DO - 10.1212/WNL.54.12.2261 ID - Raskind2000 ER - TY - JOUR AU - Rockwood, K. AU - Mintzer, J. AU - Truyen, L. AU - Wessel, T. AU - Wilkinson, D. PY - 2001 DA - 2001// TI - Effects of a flexible galantamine dose in Alzheimer’s disease: a randomised, controlled trial JO - J Neurol Neurosurg Psychiatry VL - 71 UR - https://doi.org/10.1136/jnnp.71.5.589 DO - 10.1136/jnnp.71.5.589 ID - Rockwood2001 ER - TY - JOUR AU - Tariot, P. N. AU - Solomon, P. R. AU - Morris, J. C. AU - Kershaw, P. AU - Lilienfeld, S. AU - Ding, C. PY - 2000 DA - 2000// TI - A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group JO - Neurology VL - 54 UR - https://doi.org/10.1212/WNL.54.12.2269 DO - 10.1212/WNL.54.12.2269 ID - Tariot2000 ER - TY - JOUR AU - Wilcock, G. K. AU - Lilienfeld, S. AU - Gaens, E. PY - 2000 DA - 2000// TI - Efficacy and safety of galantamine in patients with mild-to-moderate Alzheimer’s disease: multicentre randomised controlled trial. Galantamine International-1 Study Group JO - BMJ VL - 321 UR - https://doi.org/10.1136/bmj.321.7274.1445 DO - 10.1136/bmj.321.7274.1445 ID - Wilcock2000 ER - TY - JOUR AU - Koola, M. M. AU - Buchanan, R. W. AU - Pillai, A. AU - Aitchison, K. J. AU - Weinberger, D. R. AU - Aaronson, S. T. PY - 2014 DA - 2014// TI - Potential role of the combination of galantamine and memantine to improve cognition in schizophrenia JO - Schizophr Res VL - 157 UR - https://doi.org/10.1016/j.schres.2014.04.037 DO - 10.1016/j.schres.2014.04.037 ID - Koola2014 ER - TY - JOUR AU - Grossberg, G. T. AU - Edwards, K. R. AU - Zhao, Q. PY - 2006 DA - 2006// TI - Rationale for combination therapy with galantamine and memantine in Alzheimer’s disease JO - J Clin Pharmacol VL - 46 UR - https://doi.org/10.1177/0091270006288735 DO - 10.1177/0091270006288735 ID - Grossberg2006 ER - TY - JOUR AU - Haider, B. AU - Schmidt, R. AU - Schweiger, C. AU - Forstner, T. AU - Labek, A. AU - Lampl, C. PY - 2014 DA - 2014// TI - Medication adherence in patients with dementia: an Austrian cohort study JO - Alzheimer Dis Assoc Disord VL - 28 UR - https://doi.org/10.1097/WAD.0000000000000006 DO - 10.1097/WAD.0000000000000006 ID - Haider2014 ER - TY - JOUR AU - Kroger, E. AU - vanMarum, R. AU - Souverein, P. AU - Egberts, T. PY - 2010 DA - 2010// TI - Discontinuation of cholinesterase inhibitor treatment and determinants thereof in the Netherlands: a retrospecrtive cohort study JO - Drugs Aging VL - 27 UR - https://doi.org/10.2165/11538230-000000000-00000 DO - 10.2165/11538230-000000000-00000 ID - Kroger2010 ER - TY - JOUR AU - Amuah, J. E. AU - Hogan, D. B. AU - Eliasziw, M. AU - Supina, A. AU - Beck, P. AU - Downey, W. PY - 2010 DA - 2010// TI - Persistence with cholinesterase inhibitor therapy in a population-based cohort of patients with Alzheimer’s disease JO - Pharmacoepidemiol Drug Saf VL - 19 UR - https://doi.org/10.1002/pds.1946 DO - 10.1002/pds.1946 ID - Amuah2010 ER - TY - JOUR AU - Bloom, G. S. PY - 2014 DA - 2014// TI - Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis JO - JAMA Neurol VL - 71 UR - https://doi.org/10.1001/jamaneurol.2013.5847 DO - 10.1001/jamaneurol.2013.5847 ID - Bloom2014 ER - TY - JOUR AU - Rollin-Sillaire, A. AU - Breuilh, L. AU - Salleron, J. AU - Bombois, S. AU - Cassagnaud, P. AU - Deramecourt, V. PY - 2012 DA - 2012// TI - Reasons that prevent the inclusion of Alzheimer’s disease patients in clinical trials JO - Br J Clin Pharm VL - 75 UR - https://doi.org/10.1111/j.1365-2125.2012.04423.x DO - 10.1111/j.1365-2125.2012.04423.x ID - Rollin-Sillaire2012 ER - TY - JOUR AU - Snyder, H. M. AU - Corriveau, R. A. AU - Craft, S. AU - Faber, J. E. AU - Greenberg, S. M. AU - Knopman, D. PY - 2015 DA - 2015// TI - Vascular contributions to cognitive impairment and dementia including Alzheimer’s disease JO - Alzheimers Dement VL - 11 UR - https://doi.org/10.1016/j.jalz.2014.10.008 DO - 10.1016/j.jalz.2014.10.008 ID - Snyder2015 ER - TY - JOUR AU - Vidal, J. S. AU - Lacombe, J. M. AU - Dartigues, J. F. AU - Pasquier, F. AU - Robert, P. AU - Tzourio, C. PY - 2008 DA - 2008// TI - Memantine therapy for Alzheimer disease in real-world practice. An observational study in a large representative sample of French patients JO - Alzheimer Dis Assoc Disord VL - 22 UR - https://doi.org/10.1097/WAD.0b013e31815a9e10 DO - 10.1097/WAD.0b013e31815a9e10 ID - Vidal2008 ER - TY - JOUR AU - Feldman, H. H. AU - Pirttila, T. AU - Dartigues, J. F. AU - Everitt, B. AU - Baelen, B. AU - Brashear, H. R. PY - 2009 DA - 2009// TI - Analyses of mortality risk in patients with dementia treated with galantamine JO - Acta Neurol Scand VL - 119 UR - https://doi.org/10.1111/j.1600-0404.2008.01047.x DO - 10.1111/j.1600-0404.2008.01047.x ID - Feldman2009 ER - TY - JOUR PY - 2004 DA - 2004// TI - Long-term donepezil treatment in 565 patients with Alzheimer’s diease (A2000): randomised double-blind trial JO - Lancet VL - 363 UR - https://doi.org/10.1016/S0140-6736(04)16499-4 DO - 10.1016/S0140-6736(04)16499-4 ID - ref17 ER - TY - JOUR AU - Hatoum, H. T. AU - Thomas, S. K. AU - Lin, S. J. AU - Lane, R. AU - Bullock, R. PY - 2009 DA - 2009// TI - Predicting time to nursing home placement based on activities of daily living scores—a modelling analysis using data on Alzheimer’s disease patients receiving rivastigmine or donepezil JO - J Med Econ VL - 12 UR - https://doi.org/10.3111/13696990903004039 DO - 10.3111/13696990903004039 ID - Hatoum2009 ER - TY - JOUR AU - Nordström, P. AU - Religa, D. AU - Wimo, A. AU - Winblad, B. AU - Eriksdotter, M. PY - 2013 DA - 2013// TI - The use of cholinesterase inhibitors and the risk of myocardial infarction and death: a nationwide cohort study in subjects with Alzheimer’s disease JO - Eur Heart J VL - 34 UR - https://doi.org/10.1093/eurheartj/eht182 DO - 10.1093/eurheartj/eht182 ID - Nordström2013 ER - TY - JOUR AU - Geldmacher, D. S. AU - Provenzano, G. AU - McRae, T. AU - Mastey, V. AU - Leni, J. R. PY - 2003 DA - 2003// TI - Donepezil is associated with delayed nursing home placement in patients with Alzheimer’s disease JO - J Am Geriatr Soc VL - 51 UR - https://doi.org/10.1046/j.1365-2389.2003.51306.x DO - 10.1046/j.1365-2389.2003.51306.x ID - Geldmacher2003 ER - TY - JOUR AU - Schneider, L. PY - 2004 DA - 2004// TI - AD2000: donepezil in Alzheimer’s disease JO - Lancet VL - 363 UR - https://doi.org/10.1016/S0140-6736(04)16533-1 DO - 10.1016/S0140-6736(04)16533-1 ID - Schneider2004 ER - TY - JOUR AU - Periclou, A. AU - Ventura, D. AU - Rao, N. AU - Abramowitz, W. PY - 2006 DA - 2006// TI - Pharmacokinetic study of memantine in healthy and renally-impaired subjects JO - Clin Pharmacol Ther VL - 79 UR - https://doi.org/10.1016/j.clpt.2005.10.005 DO - 10.1016/j.clpt.2005.10.005 ID - Periclou2006 ER - TY - JOUR AU - Saab, B. J. AU - Roder, J. C. PY - 2011 DA - 2011// TI - Acute pharmacokinetics of memantine in the mouse JO - Pharmacology VL - 88 UR - https://doi.org/10.1159/000332829 DO - 10.1159/000332829 ID - Saab2011 ER - TY - STD TI - Matsunaga S, Kishi T, Iwata N. Combination therapy with cholinesterase inhibitors and memantine for Alzheimer’s disease: a systematic review and meta-analysis. Int J Neuropsychopharmacol. 2015;18:1–11. doi:10.1093/ijnp/pyu115. ID - ref24 ER - TY - JOUR AU - Peters, O. AU - Fuentes, M. AU - Joachim, L. K. AU - Jessen, F. AU - Luckhaus, C. AU - Kornhuber, J. PY - 2015 DA - 2015// TI - Combined treatment with memantine and galantamine-CR compared with galantamine-CR only in antidementia drug naïve patients with mild-to-moderate Alzheimer’s disease JO - Alzheimers Dement VL - 1 ID - Peters2015 ER - TY - JOUR AU - Howard, R. AU - McShane, R. AU - Lindesay, J. AU - Ritchie, C. AU - Baldwin, A. AU - Barber, R. PY - 2012 DA - 2012// TI - Donepezil and memantine for moderate-to-severe Alzheimer’s disease JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1106668 DO - 10.1056/NEJMoa1106668 ID - Howard2012 ER - TY - JOUR AU - Howard, R. AU - McShane, R. AU - Lindesay, J. AU - Ritchie, C. AU - Baldwin, A. AU - Barber, R. PY - 2015 DA - 2015// TI - Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer’s Disease (DOMINO-AD) trial: secondary and post-hoc analyses JO - Lancet Neurol VL - 14 UR - https://doi.org/10.1016/S1474-4422(15)00258-6 DO - 10.1016/S1474-4422(15)00258-6 ID - Howard2015 ER - TY - JOUR AU - Erkinjuntti, T. AU - Kurz, A. AU - Gauthier, S. AU - Bullock, R. AU - Lilienfeld, S. AU - Damaraju, C. V. PY - 2002 DA - 2002// TI - Efficacy of galantamine in probable vascular dementia and Alzheimer’s disease combined with cerebrovascular disease: a randomised trial JO - Lancet VL - 359 UR - https://doi.org/10.1016/S0140-6736(02)08267-3 DO - 10.1016/S0140-6736(02)08267-3 ID - Erkinjuntti2002 ER - TY - JOUR AU - Brookmeyer, R. AU - Corrada, M. M. AU - Curriero, F. C. AU - Kawas, C. PY - 2002 DA - 2002// TI - Survival following a diagnosis of Alzheimer disease JO - Arch Neurol VL - 59 UR - https://doi.org/10.1001/archneur.59.11.1764 DO - 10.1001/archneur.59.11.1764 ID - Brookmeyer2002 ER -